Capital Flow Monitor · Sponsors · CIK 1986248
Conceivable Life Sciences Inc.
160 MERCER STREET, NEW YORK, NY, 10012 · 917-657-2175
Other Health Care · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$33.0M
Sold
$30.5M
% sold
92.4%
Investors
20
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-15 | D ·current | 506(b) | $33.0M | $30.5M | 92.4% | 20 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Alan Murray — Executive Officer / Director, New York, NY
3 other raises
- Landbank III, LP $200K of $50.0M · 0.4%
- Global Village Fruit, Inc. $1.5M of $7.0M · 21.4%
- SAMBAZON INC $65.1M of —
- Alejandro Chavez-Badiola — Executive Officer / Director, Mexico City, O5
-
Aike Ho — Director, San Francisco, CA
1 other raise
- Arya For Work, Inc. $18.1M of $18.2M · 99.4%
- Fred Destin — Director, London, X0
-
Stuart Peterson — Director, San Francisco, CA
1 other raise
- Opyn Health, Inc. $4.5M of $5.0M · 90.0%
- Alex Christ — Director, New York, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.